Neovacular Age-related Macular Degeneration

1 clinical trials · Condition

Record	Firm	Date
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD) (NCT01988662)	Novartis Pharmaceuticals	2014-04-01

Every clearance here is in the API, with alerts when new ones post.